DoctorDevyani Holmes

Postdoctoral Fellow

Chemical and Process Engineering

  • Postdoctoral Fellow
    Chemical and Process Engineering

IMPACT SUMMARY

My research aims to improve how we understand and treat inflammation-driven disease and nerve injury.

In cardiovascular research, my 2026 first-author paper in Atherosclerosis showed that live human atherosclerotic plaques are far more permeable to inflammatory cells than previously thought, using spectral photon-counting CT to track gold-labelled monocytes. This work, and my earlier preclinical studies, helped demonstrate SPCCT as an emerging molecular imaging tool for detecting atherosclerotic disease. I have shared these findings with surgeons and registrars at Continuing Medical Education sessions, and was an Early Career Prize finalist at Queenstown Research Week in 2025.

Through a Callaghan Innovation R&D Fellowship at MARS Bioimaging Ltd, I supported the international uptake of New Zealand-developed SPCCT technology, establishing six international research collaborations across the USA and Europe.

My current spinal cord injury research is shaped by engagement with people with lived experience, including at the Spinal Cord Injury Symposium in Auckland in 2026, to keep the work focused on outcomes that matter to patients.